BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3258189)

  • 21. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplified genes in human gliomas.
    Collins VP
    Semin Cancer Biol; 1993 Feb; 4(1):27-32. PubMed ID: 8448375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.
    Pandita A; Aldape KD; Zadeh G; Guha A; James CD
    Genes Chromosomes Cancer; 2004 Jan; 39(1):29-36. PubMed ID: 14603439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
    Kubota T; Josui K; Fukutomi T; Kitajima M
    Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
    Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
    Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
    J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function.
    Ciesielski MJ; Fenstermaker RA
    Oncogene; 2000 Feb; 19(6):810-20. PubMed ID: 10698499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cells.
    Fenstermaker RA; Ciesielski MJ; Castiglia GJ
    Oncogene; 1998 Jul; 16(26):3435-43. PubMed ID: 9692551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In contrast to EGFr gene overexpression, H-ras gene expression decreases in human gliomas.
    Blumenstock M; Prosenc N; Patt S; Pfanne K; Drum F; Cervos-Navarro J
    Anticancer Res; 1991; 11(3):1353-7. PubMed ID: 1888172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of epidermal growth factor receptor amplification in malignant gliomas.
    Sauter G; Maeda T; Waldman FM; Davis RL; Feuerstein BG
    Am J Pathol; 1996 Apr; 148(4):1047-53. PubMed ID: 8644846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between EGFR overexpression and gene amplification status in central nervous system gliomas.
    Tripp SR; Willmore-Payne C; Layfield LJ
    Anal Quant Cytol Histol; 2005 Apr; 27(2):71-8. PubMed ID: 15913199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.